Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-03 8:17 pm Purchase |
2024-12-30 | 13D | CASI Pharmaceuticals, Inc. CASI |
Ho Chi Sing | 992,638 6.400% |
992,638 (New Position) |
Filing History |
| 2024-10-29 4:05 pm Purchase |
2024-09-30 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,435,000 9.200% |
305,000 (+26.99%) |
Filing History |
| 2024-08-12 08:27 am Purchase |
2024-07-15 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 3,257,891 20.940% |
420,000 (+14.80%) |
Filing History |
| 2024-07-25 8:48 pm Purchase |
2024-07-15 | 13G | CASI Pharmaceuticals, Inc. CASI |
Venrock Healthcare Capital Partners III L.P. | 1,507,040 9.990% |
1,507,040 (New Position) |
Filing History |
| 2024-06-20 9:00 pm Purchase |
2024-06-10 | 13G | CASI Pharmaceuticals, Inc. CASI |
Foresite Capital Fund VI, L.P. | 1,309,383 9.800% |
1,309,383 (New Position) |
Filing History |
| 2024-06-11 4:10 pm Sale |
2024-06-10 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,130,000 8.400% |
-1,565,000 (-58.07%) |
Filing History |
| 2024-01-26 08:31 am Purchase |
2024-01-25 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 2,695,000 19.990% |
268,000 (+11.04%) |
Filing History |
| 2023-11-09 4:13 pm Purchase |
2023-11-09 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 2,427,000 18.000% |
677,000 (+38.69%) |
Filing History |
| 2023-06-22 9:15 pm Purchase |
2023-06-16 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,750,000 13.000% |
520,000 (+42.28%) |
Filing History |
| 2023-04-18 4:00 pm Purchase |
2023-04-14 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 2,837,891 19.750% |
2,837,891 (New Position) |
Filing History |
| 2023-04-10 11:22 am Purchase |
2023-03-29 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,230,000 9.200% |
1,230,000 (New Position) |
Filing History |